Freezing treatment for prostate cancer that has come back
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a treatment that uses extreme cold to freeze and destroy cancer cells that have returned in the prostate area after radiation or surgery. It might help people who cannot have more surgery or radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has been confirmed by a biopsy or seen on an MRI or PET scan in the prostate area.
- Surgery is not a good option for you right now.
- Radiation therapy has not worked, is not recommended, or can be safely delayed.
- Your tumor is smaller than 5 centimeters (about 2 inches) across.
- The tumor does not touch the rectal wall or the muscle that controls urine flow.
- You are able to have an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment where doctors use MRI pictures to guide freezing of a prostate tumor. It may help men with smaller, well-placed prostate cancers who cannot or do not want surgery or radiation right now.
This trial tests whether freezing only the cancer area in the prostate (focal cryotherapy) can control intermediate-risk prostate cancer. It aims to limit treatment to one tumor focus while closely checking results with targeted and follow-up testing.
This trial tests using MRI and ultrasound together to guide freezing (cryoablation) treatment for prostate cancer. It may help target the tumor more precisely while avoiding areas that could cause side effects.
This study tracks outcomes for men who choose cryotherapy (freezing cancer cells) to treat prostate cancer that hasn't spread. It helps doctors understand how well this treatment works.
This trial tests whether a special gel placed between the prostate and rectum improves the safety and effectiveness of cryoablation—a freezing treatment for prostate cancer. The gel aims to protect the rectum from cold damage during the procedure.
This trial tests freezing prostate tumors (cryoablation) combined with a low-dose chemotherapy pill (metronomic cyclophosphamide) for men with metastatic prostate cancer. The goal is to see if this combination can slow the cancer's growth and improve outcomes.
Hear when a new Prostate Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.